Mafe a few enquiries this morning...it would appear that an ann. concerning another MAP type JV this time with a big pharma firm is imminent....don't quote me on it...but it was certainly worth buying a which I have done.
Info comes from a broker specializing in pharmas...
DYOR...
EB